Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management

Awgichew Shewasinad Yehualashet,1 Teshome Fentik Belachew,2 Zemene Demelash Kifle,3 Ayele Mamo Abebe4 1Pharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia; 2Department of Pharmacy, Debre Birhan Health Science College,...

Full description

Bibliographic Details
Main Authors: Yehualashet AS, Belachew TF, Kifle ZD, Abebe AM
Format: Article
Language:English
Published: Dove Medical Press 2020-09-01
Series:Vascular Health and Risk Management
Subjects:
Online Access:https://www.dovepress.com/targeting-cardiac-metabolic-pathways-a-role-in-ischemic-management-peer-reviewed-article-VHRM
id doaj-d7bf26f0c3844690a72719d36d43ce60
record_format Article
spelling doaj-d7bf26f0c3844690a72719d36d43ce602020-11-25T03:07:15ZengDove Medical PressVascular Health and Risk Management1178-20482020-09-01Volume 1635336556983Targeting Cardiac Metabolic Pathways: A Role in Ischemic ManagementYehualashet ASBelachew TFKifle ZDAbebe AMAwgichew Shewasinad Yehualashet,1 Teshome Fentik Belachew,2 Zemene Demelash Kifle,3 Ayele Mamo Abebe4 1Pharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia; 2Department of Pharmacy, Debre Birhan Health Science College, Debre Birhan, Ethiopia; 3School of Pharmacy, Department of Pharmacology, University of Gondar, Gondar, Ethiopia; 4Department of Nursing, College of Health Sciences, Debre Berhan University, Debre Berhan, EthiopiaCorrespondence: Awgichew Shewasinad YehualashetPharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, PO Box 445, Debre Berhan, EthiopiaTel +251-93-545-0290Email awgshewa@gmail.comAbstract: Among the vast number of noncommunicable diseases encountered worldwide, cardiovascular diseases accounted for about 17.8 million deaths in 2017 and ischemic heart disease (IHD) remains the single-largest cause of death in countries across all income groups. Because conventional medications are not without shortcomings and patients still refractory to these medications, scientific investigation is ongoing to advance the management of IHD, and shows a great promise for better treatment modalities, but additional research can warrant improvement in terms of the quality of life of patients. Metabolic modulation is one promising strategy for the treatment of IHD, because alterations in energy metabolism are involved in progression of the disease. Therefore, the purpose of this review was to strengthen attention toward the use of metabolic modulators and to review the current level of knowledge on cardiac energy metabolic pathways.Keywords: metabolic modulation, ischemic heart disease, cardiac energy metabolism, mitochondrial dynamicshttps://www.dovepress.com/targeting-cardiac-metabolic-pathways-a-role-in-ischemic-management-peer-reviewed-article-VHRMmetabolic modulationischemic heart diseasecardiac energy metabolismmitochondrial dynamics
collection DOAJ
language English
format Article
sources DOAJ
author Yehualashet AS
Belachew TF
Kifle ZD
Abebe AM
spellingShingle Yehualashet AS
Belachew TF
Kifle ZD
Abebe AM
Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management
Vascular Health and Risk Management
metabolic modulation
ischemic heart disease
cardiac energy metabolism
mitochondrial dynamics
author_facet Yehualashet AS
Belachew TF
Kifle ZD
Abebe AM
author_sort Yehualashet AS
title Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management
title_short Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management
title_full Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management
title_fullStr Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management
title_full_unstemmed Targeting Cardiac Metabolic Pathways: A Role in Ischemic Management
title_sort targeting cardiac metabolic pathways: a role in ischemic management
publisher Dove Medical Press
series Vascular Health and Risk Management
issn 1178-2048
publishDate 2020-09-01
description Awgichew Shewasinad Yehualashet,1 Teshome Fentik Belachew,2 Zemene Demelash Kifle,3 Ayele Mamo Abebe4 1Pharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, Debre Berhan, Ethiopia; 2Department of Pharmacy, Debre Birhan Health Science College, Debre Birhan, Ethiopia; 3School of Pharmacy, Department of Pharmacology, University of Gondar, Gondar, Ethiopia; 4Department of Nursing, College of Health Sciences, Debre Berhan University, Debre Berhan, EthiopiaCorrespondence: Awgichew Shewasinad YehualashetPharmacology and Toxicology Unit, Department of Pharmacy, College of Health Sciences, Debre Berhan University, PO Box 445, Debre Berhan, EthiopiaTel +251-93-545-0290Email awgshewa@gmail.comAbstract: Among the vast number of noncommunicable diseases encountered worldwide, cardiovascular diseases accounted for about 17.8 million deaths in 2017 and ischemic heart disease (IHD) remains the single-largest cause of death in countries across all income groups. Because conventional medications are not without shortcomings and patients still refractory to these medications, scientific investigation is ongoing to advance the management of IHD, and shows a great promise for better treatment modalities, but additional research can warrant improvement in terms of the quality of life of patients. Metabolic modulation is one promising strategy for the treatment of IHD, because alterations in energy metabolism are involved in progression of the disease. Therefore, the purpose of this review was to strengthen attention toward the use of metabolic modulators and to review the current level of knowledge on cardiac energy metabolic pathways.Keywords: metabolic modulation, ischemic heart disease, cardiac energy metabolism, mitochondrial dynamics
topic metabolic modulation
ischemic heart disease
cardiac energy metabolism
mitochondrial dynamics
url https://www.dovepress.com/targeting-cardiac-metabolic-pathways-a-role-in-ischemic-management-peer-reviewed-article-VHRM
work_keys_str_mv AT yehualashetas targetingcardiacmetabolicpathwaysaroleinischemicmanagement
AT belachewtf targetingcardiacmetabolicpathwaysaroleinischemicmanagement
AT kiflezd targetingcardiacmetabolicpathwaysaroleinischemicmanagement
AT abebeam targetingcardiacmetabolicpathwaysaroleinischemicmanagement
_version_ 1724671608093671424